Serum sclerostin as a potential biomarker of vascular and valvular types of calcification in chronic kidney disease cases with and without maintenance hemodialysis
| Autor: | Thanaa F Moghazy, Moataz Zaki, Alaa Mohamed Ismail El-Banna, Khaled Matrawy, Noha S Kandil, Moyassar Ahmad Zaki, Dalia Aly Maharem |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
business.industry Regulator 030209 endocrinology & metabolism General Medicine Maintenance hemodialysis medicine.disease Gastroenterology 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine chemistry Internal medicine Potential biomarkers medicine Sclerostin 030212 general & internal medicine business Vascular calcification Kidney disease Calcification |
| Zdroj: | Alexandria Journal of Medicine. 55:15-24 |
| ISSN: | 2090-5076 2090-5068 |
| DOI: | 10.1080/20905068.2019.1592930 |
| Popis: | Introduction: Vascular calcification (VC) is one of the factors involved in the increased cardiovascular risk observed in chronic kidney disease. Sclerostin is known to be a down regulator ... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|